PHIBRO ANIMAL HEALTH CORP files with the SEC under CIK 0001069899 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PAHC Form 4 activity by transaction type, last 90 days
Form 4 transaction type
Transactions
Shares
Total value
Grant or award
10
46,110
Other acquisition / disposition
6
5,001
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PAHC insider transactions (Form 4)
82
59 Form 4 filings on record, the earliest from Aug 15, 2025, newest first. Filing history page 1 of 2.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F3 (shares): This amendment to the Form 4 filed on August 10, 2026 (the "Original Form 4") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects… Full note on SEC EDGAR
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F3 (shares): This amendment to the Form 4 filed on August 10, 2026 (the "Original Form 4") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects… Full note on SEC EDGAR
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F2 (shares): The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
Footnote F1 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Footnote F1 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Footnote F1 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Footnote F1 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Footnote F1 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Footnote F1 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Footnote F1 (price): The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.66 to $31.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.225 to $56.21. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.235 to $56.51.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.825 to $57.72.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.965 to $58.31.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.995.
Footnote F8 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.835.
Footnote F9 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.50.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.51 to $55.40. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.51 to $56.50.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.53 to $56.875.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.97.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.775.
Footnote F8 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.16 to $53.09.
Footnote F9 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.22 to $53.39.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.905 to $55.88. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.56.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.665.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.51 to $54.50.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.515 to $54.61.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22.
Footnote F9 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79.
Footnote F10 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.23 to $54.075. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.23 to $54.385.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.27 to $54.26.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.28 to $54.51.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.44 to $53.435. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.53 to $53.70.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.69 to $55.65.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.76 to $56.745.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.76 to $56.91.
Footnote F8 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.12 to $57.06.
Footnote F9 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.14 to $57.24.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.26 to $52.13. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.29 to $52.21.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.35 to $53.295.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.365 to $53.88.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.19 to $52.18.
Footnote F8 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.195 to $53.125.
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.48 to $49.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.755 to $51.75. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.065.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.275 to $52.27.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.21 to $54.10.
Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.27 to $54.355.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.965 to $50.935. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $51.89.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.92 to $52.06.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.61 to $52.345. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $51.875.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.90 to $52.05.
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.10 to $52.09. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.10 to $52.30.
Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.11 to $52.04.
Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.205 to $52.21.
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
PHIBRO ANIMAL HEALTH CORP (PAHC) had 16 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for PAHC runs to 59 Form 4 filings, the earliest from 2025-08-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PAHC stock?
No insider purchases of PAHC were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling PAHC stock?
No insider sales of PAHC were filed in the last 90 days. 116 sales are on record for this company.
Where can I see PAHC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PAHC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Glenn David - Officer
